A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer’s disease, and brain injuries.
A team of researchers at Penn State identified a set of four, or even three, molecules that could convert glial cells—which normally provide support and insulation for neurons—into new neurons. A paper describing the approach appears online in the journal Stem Cell Reports on February 7, 2019.
“The biggest problem for brain repair is that neurons don’t regenerate after brain damage, because they don’t divide,” said Gong Chen, professor of biology and Verne M. Willaman Chair in Life Sciences at Penn State and leader of the research team. “In contrast, glial cells, which gather around damaged brain tissue, can proliferate after brain injury. I believe turning glial cells that are the neighbors of dead neurons into new neurons is the best way to restore lost neuronal functions.”
Chen’s team previously published research describing a sequence of nine small molecules that could directly convert human glial cells into neurons, but the large number of molecules and the specific sequence required for reprogramming the glial cells complicated the transition to a clinical treatment. In the current study, the team tested various numbers and combinations of molecules to identify a streamlined approach to the reprogramming of astrocytes, a type of glial cells, into neurons.
“We identified the most efficient chemical formula among the hundreds of drug combinations that we tested,” said Jiu-Chao Yin, a graduate student in biology at Pen State who identified the ideal combination of small molecules. “By using four molecules that modulate four critical signaling pathways in human astrocytes, we can efficiently turn human astrocytes—as many as 70 percent—into functional neurons.”
The resulting chemically converted neurons can survive more than seven months in a culture dish in the lab. They form robust neural networks and send chemical and electrical signals to each other, as normal neurons do inside the brain.
Using three of the small molecules instead of four also results in the conversion of astrocytes into neurons, but the conversion rate drops by about 20 percent. The team also tried using only one of the molecules, but this approach did not induce conversion.
Chen and his team had previously developed a gene therapy technology to convert astrocytes into functional neurons, but due to the excessive cost of gene therapy—which can cost a patient half a million dollars or more—the team has been pursuing more economical approaches to convert glial cells into neurons. The delivery system for gene therapies is also more complex, requiring the injection of viral particles into the human body, whereas the small molecules in the new method can be chemically synthesized and packaged into a pill.
“The most significant advantage of the new approach is that a pill containing small molecules could be distributed widely in the world, even reaching rural areas without advanced hospital systems,” said Chen. “My ultimate dream is to develop a simple drug delivery system, like a pill, that can help stroke and Alzheimer’s patients around the world to regenerate new neurons and restore their lost learning and memory capabilities.”
The researchers acknowledge that many technical issues still need to be resolved before a drug using small molecules could be created, including the specifics of drug packaging and delivery. They also plan to investigate potential side effects of this approach in future studies in order to develop the safest drug pills. Nonetheless, the research team is confident that this combination of molecules has promising implications for future drug therapies to treat individuals with neurological disorders.
“Our years of effort in discovering this simplified drug formula take us one step closer to reaching our dream,” said Chen.
The Latest on: Small molecules
via Google News
The Latest on: Small molecules
- Rotten egg gas may help protect aging brain cells from Alzheimer’s diseaseon January 12, 2021 at 4:00 pm
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a face-lift thanks to Johns Hopkins Medicine researchers.
- Metabolism may play role in recurrent major depressionon January 12, 2021 at 1:27 pm
Researchers at University of California San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites—small molecules produced by the process of ...
- UCSD Scientists Find Certain Metabolisms May Be Linked To Recurring Depressionon January 12, 2021 at 11:42 am
Researchers at the UC San Diego School of Medicine found that certain metabolites -- small molecules produced by the process of metabolism -- may be predictive indicators for people at risk for ...
- Teon Therapeutics Appoints Glen Giovannetti as Independent Board Memberon January 12, 2021 at 7:08 am
Teon Therapeutics, a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic ...
- Brain cell molecules shown in first-ever nanoscale 3-D images of whole living cellson January 12, 2021 at 6:32 am
A new fluorescence microscopy technique has produced the world's first nanoscale 3-D images of molecules in a whole, living cell, researchers at KTH Royal Institute of Technology reported.
- Inside potential $1B deal for Ribometrix: A look at startup’s science, historyon January 12, 2021 at 3:23 am
Ribometrix, a Durham company specializing in RNA-based therapeutics, has formed a drug discovery and development collaboration with Genentech that could be worth more than $1 billion. Heres a look at ...
- Small Pilot Study Indicates Qualia Life May Increase NAD+on January 12, 2021 at 3:22 am
Neurohacker Collective announced the preliminary results of a small pilot study done in collaboration with Longevity Diagnostics Research on its healthy aging supplement Qualia Life. The results ...
- A new approach to film atoms and molecules vibrating inside solidson January 11, 2021 at 10:20 am
Theoretical and experimental scientists have come together to watch solids vibrate. Atoms or molecules constitute everything around us. In many solids, like common salt or iron, they are neatly ...
- Designer Molecules for Fundamental-Symmetry Testson January 10, 2021 at 4:00 pm
Researchers design radioactive molecules that might have exceptional sensitivity to the symmetry violations explaining the matter-antimatter imbalance of the Universe.
- DiCE Molecules Announces $80 Million Series C Financingon January 8, 2021 at 10:41 pm
DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology, today announced the completion ...
via Bing News